Skip to content

Clinical trials

Cardiovascular Diseases trials in the Philippines

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Philippines Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20051
20081
20094
20101
20111
20122
20142
20182
20231
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting3
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
AstraZeneca3
Boehringer Ingelheim2
Novartis2
Novartis Pharmaceuticals2
Population Health Research Institute2
Bayer1
Sanofi1
Takeda1
UPecon Foundation, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases19
Myocardial Infarction4
Acute Coronary Syndrome3
Atherosclerosis3
Heart Diseases3
Hypertension3
Stroke3
Coronary Disease2
Diabetes Mellitus, Type 22
Neoplasms2

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.